Menzies, A. M., Yeh, I., Botton, T., Bastian, B. C., Scolyer, R. A., & Long, G. V. (2015). Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. Pigment Cell Melanoma Res.

Menzies, Alexander M., Iwei Yeh, Thomas Botton, Boris C. Bastian, Richard A. Scolyer, ja Georgina V. Long. "Clinical Activity of the MEK Inhibitor Trametinib in Metastatic Melanoma Containing BRAF Kinase Fusion." Pigment Cell Melanoma Res 2015.

Menzies, Alexander M., et al. "Clinical Activity of the MEK Inhibitor Trametinib in Metastatic Melanoma Containing BRAF Kinase Fusion." Pigment Cell Melanoma Res 2015.